Protocol·One

BPC-157 · For rotator cuff injury

BPC-157 for rotator cuff injuries

You tweaked your shoulder. Strain, partial tear, or impingement. BPC-157 worth trying?

S-Tier Recovery Moderate anecdotal

Why people use BPC-157 for rotator cuff injury

You tweaked your shoulder. Strain, partial tear, or impingement. BPC-157 worth trying? The honest answer: it is mixed - some real signal, a lot of anecdote. Most popular off-label use among recreational athletes 35+.

This page covers what's known, what's not, and what the editorial take is for normal humans considering BPC-157 for rotator cuff injury.

What the evidence says

Evidence tier: Moderate anecdotal. Strong real-world anecdotal track record; mechanism extrapolates from related research.

  • Most popular off-label use among recreational athletes 35+.
  • Anecdotal reports particularly strong for partial tears that haven't responded to PT.
  • No RCTs specific to rotator cuff exist; mechanism extrapolates from tendon healing data.

Protocol notes

Subcutaneous injection in shoulder area or systemic dosing. 250-500mcg/day for 4-6 weeks.

Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.

What to skip

  • Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
  • Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
  • Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.

Where to go next

New to peptides? Start with the foundations ->